Company CVAbout Biophytis SA 
Biophytis SA
Pharmaceuticals & Biotechnology
Biophytis SA, formerly Institut Biophytis Sas is a France-based company engaged in the healthcare industry. The Company is a biotechnology entity specialized in the development of drug candidates to treat ageing diseases. Its two programs relate to sarcopenia (loss of muscle functionality) and Age Related Macular Degeneration (ARMD). Biophytis SA is engaged in the clinical and regulatory development of its drug candidates, such as Sarconeos (BIO101) and Macuneos (BIO201), simultaneously in the United States and domestic market.
Company Coordinates
Company Details
14 avenue de l'Opera , PARIS None : 75001
Registrar Details
ShareholdingShareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding)
No data for shareholding present.
Board of DirectorsManagement
Designation
Mr. Stanislas Veillet
Chairman of the Board, Chief Executive Officer
Mr. Dimitri Batsis
Director
Ms. Jean Franchi
Director
Ms. Micheline Kergoat
Director
Dr. Eric Rowinsky
Director
Ms. Nadine Coulm
Independent Director
Stock DNARevenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
Pharmaceuticals & Biotechnology
EUR 1 Million ()
NA (Loss Making)
NA
0.00%
-0.84
110.61%
-0.14
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
